4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-046826
Director sold 3,750 shares at an average $32.83 ($123,112)
- Director acquired 3,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Swisher Daniel N JR Director | 2023-09-01 | Option exercise 10b5-1 | +1,550 | $6.55 | $10,153 | 1,550 | D |
| Swisher Daniel N JR Director | 2023-09-01 | Sale 10b5-1 | −1,550 | $32.73 | $50,732 | 0 | D |
| Swisher Daniel N JR Director | 2023-09-05 | Option exercise 10b5-1 | +2,200 | $5.86 | $12,892 | 2,200 | D |
| Swisher Daniel N JR Director | 2023-09-05 | Sale 10b5-1 | −2,200 | $32.90 | $72,380 | 0 | D |
| Derivatives | |||||||
| Swisher Daniel N JR Director | 2023-09-01 | Option exercise · Stock option (right to buy) 10b5-1 | −1,550 | 0 | D | ||
| Swisher Daniel N JR Director | 2023-09-06 | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 22,150 | D | ||
| Open-market sales · 3,750 sh · avg $32.83 · $123,112 | |||||||
Loading xslF345X05/ownership.xml…